Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NBIX · as of Jun 8, 2026
Key Statistics
Explore Neurocrine Biosciences, Inc. Data
nbix stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 37 · Buy rate: 86.5%
The NBIX analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month price target is $186.43, representing +13.76% upside from the current price of $163.88.
Competitors & Peers
nbix competitorsNBIX
COO
ELAN
HOLX
ICLR
RDYStock Performance
Full HistoryAbout Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia…
what is neurocrine biosciences, inc. · nbix stock overview · neurocrine biosciences, inc. company profile · who is neurocrine biosciences, inc. ceo · nbix NASDAQ · neurocrine biosciences, inc. headquarters · neurocrine biosciences, inc. business segments
About Stock Overview & Key Data
Neurocrine Biosciences, Inc. (NBIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 23, 1996. As of the latest trading session, NBIX stock price is $163.88, with a market capitalization of $16.5B. The stock has returned +30.34% over the past 12 months and +15.55% year-to-date.
According to 37 Wall Street analysts, the consensus rating for Neurocrine Biosciences, Inc. stock is Buy, with an average 12-month price target of $186.43. In fiscal year 2025, Neurocrine Biosciences, Inc. reported revenue of $2.9B and net income of $478.6M. For detailed data — including Neurocrine Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Neurocrine Biosciences, Inc. (NBIX) stock price is $163.88. The stock is traded on NASDAQ under the ticker symbol NBIX. The 52-week range is $122.14 – $168.00.